Pharmaceutical company Blue Jet Healthcare has raised Rs 252 crore from anchor investors ahead of its IPO. The company has allotted equity shares at the upper end of the price band set for the initial public offering. The IPO is expected to raise approximately Rs 799-840.27 crore. Blue Jet Healthcare focuses on the collaboration, development, and manufacturing of pharmaceutical products. The IPO is an entirely Offer for Sale (OFS) component by promoters Akshay Bansarilal Arora and Shiven Akshay Arora.

Indian equity markets opened higher on Thursday, led by banking, financial, and IT stocks ahead of the release of the Reserve Bank of India’s policy meeting minutes. The BSE Sensex and Nifty50 were trading higher. Experts have a positive outlook on the near-term market. Global markets settled higher and Asian markets advanced. Oil prices slipped, while the Indian rupee strengthened against the US dollar.